Minimally Modified Low Density Lipoprotein Induces Monocyte Chemotactic Protein 1 in Human Endothelial Cells and Smooth Muscle Cells

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1990 Jul 1

PMID 1695010

Citations 263

Authors

S D Cushing

J A Berliner

A J Valente

M C Territo

M Navab

F Parhami

R Gerrity

C J Schwartz

A M Fogelman

Affiliations

Soon will be listed here.

Abstract

After exposure to low density lipoprotein (LDL) that had been minimally modified by oxidation (MM-LDL), human endothelial cells (EC) and smooth muscle cells (SMC) cultured separately or together produced 2- to 3-fold more monocyte chemotactic activity than did control cells or cells exposed to freshly isolated LDL. This increase in monocyte chemotactic activity was paralleled by increases in mRNA levels for a monocyte chemotactic protein 1 (MCP-1) that is constitutively produced by the human glioma U-105MG cell line. Antibody that had been prepared against cultured baboon smooth muscle cell chemotactic factor (anti-SMCF) did not inhibit monocyte migration induced by the potent bacterial chemotactic factor f-Met-Leu-Phe. However, anti-SMCF completely inhibited the monocyte chemotactic activity found in the media of U-105MG cells, EC, and SMC before and after exposure to MM-LDL. Moreover, monocyte migration into the subendothelial space of a coculture of EC and SMC that had been exposed to MM-LDL was completely inhibited by anti-SMCF. Anti-SMCF specifically immunoprecipitated 10-kDa and 12.5-kDa proteins from EC. Incorporation of [35S]methionine into the immunoprecipitated proteins paralleled the monocyte chemotactic activity found in the medium of MM-LDL stimulated EC and the levels of MCP-1 mRNA found in the EC. We conclude that (i) SMCF is in fact MCP-1 and (ii) MCP-1 is induced by MM-LDL.

Citing Articles

LEVEL OF MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) AND PATTERN OF INJURIES IN POLYTRAUMA PATIENTS.

Balogun M Ann Ib Postgrad Med. 2025; 22(2):42-46.

PMID: 40007704 PMC: 11848364.

Chronic inflammation and vascular cell plasticity in atherosclerosis.

Lin A, Miano J, Fisher E, Misra A Nat Cardiovasc Res. 2024; 3(12):1408-1423.

PMID: 39653823 DOI: 10.1038/s44161-024-00569-y.

A systematic review and meta-analysis of blood level of MCP-1/CCL-2 in severe and uncomplicated malaria.

Kotepui M, Kwankaew P, Mahittikorn A, Kotepui K, Masangkay F, Wattanapisit A Sci Rep. 2024; 14(1):28738.

PMID: 39567619 PMC: 11579328. DOI: 10.1038/s41598-024-80201-y.

Role of C-Reactive Protein, An Inflammatory Biomarker in The Development of Atherosclerosis and Its Treatment.

Prasad K Int J Angiol. 2024; 33(4):271-281.

PMID: 39502349 PMC: 11534478. DOI: 10.1055/s-0044-1788296.

Serum and urinary monocyte chemoattractant protein-1 as markers of inflammation and renal damage in dogs with naturally occurring leishmaniosis.

Pantaleo V, Furlanello T, Ventura L, Solano-Gallego L Parasit Vectors. 2024; 17(1):366.

PMID: 39210379 PMC: 11363603. DOI: 10.1186/s13071-024-06432-0.

References

Valente A, Graves D, Vialle-Valentin C, Delgado R, Schwartz C . Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry. 1988; 27(11):4162-8. DOI: 10.1021/bi00411a039. View

Wahl S, Hunt D, Wakefield L, McCartney-Francis N, Wahl L, Roberts A . Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A. 1987; 84(16):5788-92. PMC: 298948. DOI: 10.1073/pnas.84.16.5788. View

Palinski W, Rosenfeld M, Yla-Herttuala S, Gurtner G, Socher S, Butler S . Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A. 1989; 86(4):1372-6. PMC: 286692. DOI: 10.1073/pnas.86.4.1372. View

Boyd H, Gown A, Wolfbauer G, Chait A . Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am J Pathol. 1989; 135(5):815-25. PMC: 1880109. View

Haberland M, Fong D, Cheng L . Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science. 1988; 241(4862):215-8. DOI: 10.1126/science.2455346. View

Quinn M, Parthasarathy S, Fong L, Steinberg D . Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci U S A. 1987; 84(9):2995-8. PMC: 304787. DOI: 10.1073/pnas.84.9.2995. View

MORTON R, West G, Hoff H . A low density lipoprotein-sized particle isolated from human atherosclerotic lesions is internalized by macrophages via a non-scavenger-receptor mechanism. J Lipid Res. 1986; 27(11):1124-34. View

Robinson E, Yoshimura T, Leonard E, Tanaka S, Griffin P, Shabanowitz J . Complete amino acid sequence of a human monocyte chemoattractant, a putative mediator of cellular immune reactions. Proc Natl Acad Sci U S A. 1989; 86(6):1850-4. PMC: 286802. DOI: 10.1073/pnas.86.6.1850. View

Ross R . The pathogenesis of atherosclerosis--an update. N Engl J Med. 1986; 314(8):488-500. DOI: 10.1056/NEJM198602203140806. View

10.

Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162(1):156-9. DOI: 10.1006/abio.1987.9999. View

11.

Metcalf D . The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature. 1989; 339(6219):27-30. DOI: 10.1038/339027a0. View

12.

Berliner J, Territo M, Almada L, Carter A, Shafonsky E, Fogelman A . Monocyte chemotactic factor produced by large vessel endothelial cells in vitro. Arteriosclerosis. 1986; 6(3):254-8. DOI: 10.1161/01.atv.6.3.254. View

13.

Yoshimura T, Yuhki N, Moore S, Appella E, Lerman M, Leonard E . Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett. 1989; 244(2):487-93. DOI: 10.1016/0014-5793(89)80590-3. View

14.

Lo S, Detmers P, Levin S, Wright S . Transient adhesion of neutrophils to endothelium. J Exp Med. 1989; 169(5):1779-93. PMC: 2189299. DOI: 10.1084/jem.169.5.1779. View

15.

Strieter R, Wiggins R, Phan S, Wharram B, Showell H, Remick D . Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells. Biochem Biophys Res Commun. 1989; 162(2):694-700. DOI: 10.1016/0006-291x(89)92366-8. View

16.

Graves D, Jiang Y, Williamson M, Valente A . Identification of monocyte chemotactic activity produced by malignant cells. Science. 1989; 245(4925):1490-3. DOI: 10.1126/science.2781291. View

17.

Yoshimura T, Robinson E, Tanaka S, Appella E, Kuratsu J, Leonard E . Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J Exp Med. 1989; 169(4):1449-59. PMC: 2189237. DOI: 10.1084/jem.169.4.1449. View

18.

Yoshimura T, Robinson E, Tanaka S, Appella E, Leonard E . Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes. J Immunol. 1989; 142(6):1956-62. View

19.

Navab M, Hough G, Stevenson L, Drinkwater D, Laks H, Fogelman A . Monocyte migration into the subendothelial space of a coculture of adult human aortic endothelial and smooth muscle cells. J Clin Invest. 1988; 82(6):1853-63. PMC: 442764. DOI: 10.1172/JCI113802. View

20.

Fogelman A, Elahi F, Sykes K, Van Lenten B, Territo M, Berliner J . Modification of the Recalde method for the isolation of human monocytes. J Lipid Res. 1988; 29(9):1243-7. View